Michael Patrick Miller Puma Biotechnology, Inc. (PBYI) insider trading activity

Michael Patrick Miller is Director of PUMA BIOTECHNOLOGY, INC.. Currently has a direct ownership of 54,000 shares of PBYI, which is worth approximately $267,300. The most recent transaction as insider was on Nov 11, 2025, when has been sold 20,000 shares (Common Stock) at a price of $4.86 per share, resulting in proceeds of $97,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54K

27.03% 3M change

14.89% 12M change

Total Value Held $267,300

MICHAEL PATRICK MILLER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2025	SELL Open market or private sale	$97,200 $4.86 p/Share	20,000 Reduced 27.03%	54,000 Common Stock
Jun 11 2025	BUY Grant, award, or other acquisition	-	27,000 Added 26.73%	74,000 Common Stock
Aug 12 2024	SELL Open market or private sale	$81,519 $3.49 p/Share	23,358 Reduced 33.2%	47,000 Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	27,000 Added 22.07%	95,358 Common Stock
Nov 07 2023	SELL Open market or private sale	$70,750 $2.83 p/Share	25,000 Reduced 36.57%	43,358 Common Stock
Jun 13 2023	SELL Open market or private sale	$46,575 $3.45 p/Share	13,500 Reduced 24.61%	41,358 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	27,000 Added 28.31%	68,358 Common Stock
Aug 09 2022	SELL Open market or private sale	$88,750 $3.55 p/Share	25,000 Reduced 31.31%	54,858 Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	27,000 Added 25.27%	79,858 Common Stock
Mar 16 2022	SELL Open market or private sale	$71,828 $2.8 p/Share	25,653 Reduced 32.67%	52,858 Common Stock
Jun 15 2021	BUY Grant, award, or other acquisition	-	27,858 Added 26.19%	78,511 Common Stock

Also insider at

BTAI

BioXcel Therapeutics, Inc. Healthcare

Director

MPM